Delivery Order SPE2DR25D1205-SPE2DR26F0VR7
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,540.74 to AmerisourceBergen Drug Corp for Xyosted 75 mg/0.5 ml auto-injector supplies. This competitively awarded, non-set-aside contract is a firm fixed-price delivery order with a completion date of September 29, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Xyosted 100 mg/0.5 mL auto-injector units, valued at $1,384.82 under a firm fixed price contract structure. This delivery order represents a competitive award with no set-aside designation and is scheduled for completion by September 17, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Xyosted 75 mg/0.5 ml auto-injector units, valued at $2,353.38. This was a competitively awarded, firm fixed-price delivery order with an ultimate completion date of August 5, 2025. The contract contains no set-aside designation, and performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $3,046.96 to AmerisourceBergen Drug Corp for the supply of Xyosted 50 mg/0.5 ml auto-injector units. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and was executed on June 25, 2025, with an ultimate completion date of June 26, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $1,086.44 to AmerisourceBergen Drug Corp for Xyosted 75 mg/0.5 mL auto-injector supplies, with an ultimate completion date of September 15, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and is being fulfilled from the vendor's location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical distributor supporting federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $1,429.20 to AmerisourceBergen Drug Corp for Xyosted 100 mg/0.5 ml auto-injector units. This is a firm fixed price, non-set-aside contract with an ultimate completion date of September 11, 2025, issued on September 10, 2025. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $2,230.21 to AmerisourceBergen Drug Corp for Xyosted 100 mg/0.5 ml auto-injector units on August 6, 2025, with completion targeted for August 7, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitively awarded procurement from AmerisourceBergen's existing pharmaceutical supply contract with DLA. The product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $1,372.49 to AmerisourceBergen Drug Corp for the supply of Xyosted 100 mg/0.5 mL auto-injector units. This is a firm fixed price, competitively awarded contract with no set-aside designation, completed on August 19, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, which serves as the company's place of performance for this federal procurement. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,667.86 to AmerisourceBergen Drug Corp for Xyosted 75 mg/0.5 ml auto-injector supplies. This firm fixed-price, non-set-aside contract was awarded on September 10, 2025, with an ultimate completion date of September 11, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a continuation of the vendor's extensive...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of Xyosted 50 mg/0.5 ml auto-injector units with a ceiling value of $1,314.75 and a completion date of October 23, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award supporting federal medical procurement needs. The contract is performed at the awardee's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- SPE2DR25D1205Indefinite Delivery Contract
- SPE2DR25D1205-SPE2DR26F0VR7Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,356.53 to AmerisourceBergen Drug Corp for Xyosted 75 mg/0.5 ml auto-injector supplies. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by October 27, 2025. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen supplies an extensive portfolio of medications and medical supplies to support military and veteran healthcare systems. The Xyosted delivery represents one of numerous pharmaceutical acquisitions through this prime vendor contract, which enables flexible sourcing of specialty medications, generic drugs, and medical devices across multiple therapeutic domains for Defense Health Agency customers and other federal healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 10/24/25 |